Controlled Angiogenesis in the Heart by Cell-Based Expression of Specific Vascular Endothelial Growth Factor Levels
- 1 October 2012
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy Methods
- Vol. 23 (5) , 346-356
Abstract
Vascular endothelial growth factor (VEGF) can induce normal angiogenesis or the growth of angioma-like vascular tumors depending on the amount secreted by each producing cell because it remains localized in the microenvironment. In order to control the distribution of VEGF expression levels in vivo, we recently developed a high-throughput fluorescence-activated cell sorting (FACS)-based technique to rapidly purify transduced progenitors that homogeneously express a specific VEGF dose from a heterogeneous primary population. Here we tested the hypothesis that cell-based delivery of a controlled VEGF level could induce normal angiogenesis in the heart, while preventing the development of angiomas. Freshly isolated human adipose tissue–derived stem cells (ASC) were transduced with retroviral vectors expressing either rat VEGF linked to a FACS-quantifiable cell-surface marker (a truncated form of CD8) or CD8 alone as control (CTR). VEGF-expressing cells were FACS-purified to generate populations producing either a specific VEGF level (SPEC) or uncontrolled heterogeneous levels (ALL). Fifteen nude rats underwent intramyocardial injection of 107 cells. Histology was performed after 4 weeks. Both the SPEC and ALL cells produced a similar total amount of VEGF, and both cell types induced a 50%–60% increase in both total and perfused vessel density compared to CTR cells, despite very limited stable engraftment. However, homogeneous VEGF expression by SPEC cells induced only normal and stable angiogenesis. Conversely, heterogeneous expression of a similar total amount by the ALL cells caused the growth of numerous angioma-like structures. These results suggest that controlled VEGF delivery by FACS-purified ASC may be a promising strategy to achieve safe therapeutic angiogenesis in the heart.Keywords
This publication has 36 references indexed in Scilit:
- Therapeutic angiogenesis due to balanced single‐vector delivery of VEGF and PDGF‐BBThe FASEB Journal, 2012
- Generation of Human Adult Mesenchymal Stromal/Stem Cells Expressing Defined Xenogenic Vascular Endothelial Growth Factor Levels by Optimized Transduction and Flow Cytometry PurificationTissue Engineering Part C: Methods, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Myocardial regeneration potential of adipose tissue-derived stem cellsBiochemical and Biophysical Research Communications, 2010
- Extracellular matrix, inflammation, and the angiogenic responseCardiovascular Research, 2010
- Cultured and freshly isolated adipose tissue-derived cells: fat years for cardiac stem cell therapyEuropean Heart Journal, 2009
- Human Studies of Angiogenic Gene TherapyCirculation Research, 2009
- Spontaneously beating cardiomyocytes derived from white mature adipocytesCardiovascular Research, 2009
- Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemiaThe FASEB Journal, 2006
- The athymic nude ratClinical Immunology and Immunopathology, 1980